Go Deep
Krebs Biochemicals & Industries Limited
Krebs Biochemicals & Industries Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -14,172 | -10.0 | -0.86 | -1.66 | 65.60 |
| Oct 2026 | -14,473 | -9.8 | -0.84 | -1.66 | 63.96 |
| Oct 2026 | -14,690 | -9.8 | -0.78 | -1.66 | 63.96 |
| Oct 2026 | -14,363 | -9.0 | -0.79 | -1.66 | 58.86 |
| Oct 2026 | -14,407 | -9.1 | -0.76 | -1.66 | 59.72 |
| Oct 2026 | -14,030 | -8.9 | -0.74 | -1.66 | 57.96 |
| Oct 2026 | -13,902 | -8.6 | -0.74 | -1.66 | 56.00 |
| Oct 2026 | -13,908 | -8.6 | -0.75 | -1.66 | 56.00 |
| Oct 2026 | -14,629 | -8.6 | -0.75 | -1.66 | 56.00 |
| Oct 2026 | -14,629 | -8.6 | -0.75 | -1.66 | 56.00 |
| Oct 2026 | -18,817 | -8.7 | -0.75 | -1.66 | 56.64 |
| Oct 2026 | -18,864 | -8.8 | -0.76 | -1.66 | 57.29 |
| Oct 2026 | -19,088 | -9.2 | -0.80 | -1.66 | 60.41 |
| Oct 2026 | -19,118 | -9.3 | -0.81 | -1.66 | 60.82 |
| Oct 2026 | -19,072 | -9.2 | -0.80 | -1.66 | 60.19 |
| Oct 2026 | -19,072 | -9.2 | -0.80 | -1.66 | 60.19 |
| Oct 2026 | -19,072 | -9.2 | -0.80 | -1.66 | 60.19 |
| Oct 2026 | -18,906 | -8.8 | -0.77 | -1.66 | 57.88 |
| Oct 2026 | -18,906 | -8.8 | -0.77 | -1.66 | 57.88 |
| Oct 2026 | -18,776 | -8.6 | -0.74 | -1.66 | 56.06 |
Krebs Biochemicals & Industries Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 69,835,000.0 | 68,091,000.0 | 72,742,000.0 | 41,674,000.0 |
| Net Profit | -24,848,000.0 | -23,396,000.0 | -31,265,000.0 | -61,428,000.0 |
| EPS | -1.1 | -1.1 | -1.4 | -2.9 |
Krebs Biochemicals & Industries Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 237,316,000.0 | 433,119,000.0 | 504,215,000.0 | 521,344,000.0 | — |
| Net Profit | -169,331,000.0 | -269,393,000.0 | -197,284,000.0 | -246,919,000.0 | — |
| EPS | -7.8 | -12.5 | -9.2 | -11.3 | — |
Krebs Biochemicals & Industries Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,632,467,000.0 | 1,690,356,000.0 | 1,781,747,000.0 | 1,749,817,000.0 | — |
| Total Liabilities | 3,260,014,000.0 | 3,152,744,000.0 | 2,973,914,000.0 | 2,744,440,000.0 | — |
| Total Equity | -1,627,547,000.0 | -1,462,388,000.0 | -1,192,167,000.0 | -994,623,000.0 | — |
Owes vs Owns
Krebs Biochemicals & Industries Limited owed ₹2.00 for every ₹1 it owned in Mar 2026, up from ₹1.57 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 2.00× | 1.87× | 1.67× | 1.57× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Krebs Biochemicals & Industries Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Inventory 3.5%Fixed assets (tangible) 87.8%Long-term investments 1.7%Other assets 6.9%
How it's funded — Mar 2026
Short-term debt 18.8%Long-term debt 50.2%Payables 4.2%Other liabilities 26.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.0 | 0.3 | 0.1 | 0.0 |
| Receivables | 0.0 | 0.1 | 1.9 | 0.5 |
| Inventory | 5.7 | 6.0 | 9.8 | 11.9 |
| Fixed assets (tangible) | 143.3 | 146.5 | 149.7 | 149.0 |
| Intangible assets | 0.3 | 2.3 | 2.5 | 2.7 |
| Long-term investments | 2.7 | 2.9 | 2.5 | 2.4 |
| Other assets | 11.2 | 11.0 | 11.6 | 8.4 |
| Liabilities & equity | ||||
| Short-term debt | 61.3 | 51.0 | 10.2 | 10.1 |
| Long-term debt | 163.6 | 161.2 | 183.5 | 173.2 |
| Payables | 13.8 | 18.2 | 19.0 | 15.3 |
| Other liabilities | 87.4 | 84.9 | 84.7 | 75.8 |
| Shareholders' equity | -162.8 | -146.2 | -119.2 | -99.5 |
| Net tangible assets | -163.0 | -148.6 | -121.7 | -102.1 |
Krebs Biochemicals & Industries Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -19,205,000.0 | -78,910,000.0 | 23,649,000.0 | -247,132,000.0 | — |
| Investing Activities | -36,358,000.0 | -49,696,000.0 | -78,167,000.0 | -126,450,000.0 | — |
| Financing Activities | 55,438,000.0 | 128,648,000.0 | 55,032,000.0 | 373,433,000.0 | — |